BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting

- Scolyer, Richard A., Atkinson, Victoria, Ch'ng, Sydney, Colebatch, Andrew J., Daneshvar, Dariush, Pires da Silva, Ines, Dawson, Tamara, Ferguson, Peter M., Foster-Smith, Erwin, Fox, Stephen B., Gill, Anthony J., Gupta, Ruta, Gyorki, David E., Henderson, MA, Hong, AM, Howle, JR, Jackett, LA, James, C, Lee, CS, Lochhead, A, Loh, D, McArthur, GA, McLean, CA, Lambie, Duncan, Menzies, AM, Nieweg, OE, O'Brien, BH, Pennington, TE, Potter, AJ, Prakash, S, Rawson, RV, Read, RL, Rtshiladze, MA, Shannon, KF, O'Toole, Sandra, Smithers, BM, Spillane, AJ, Stretch, JR, Thompson, JF, Tucker, P, Varey, AHR, Vilain, Ricardo E., Wood, BA, Long, GV, Saw, Robyn P. M., Amanuel, Benhur, Angel, Christopher M., Button-Sloan, Alison E., Carlino, Matteo S.

Confocal microscopy, dermoscopy, and histopathology features of atypical intraepidermal melanocytic proliferations associated with evolution to melanoma in situ

- Rocha, Lilian K. F. L., Vilain, Ricardo E., Scolyer, Richard A., Lo, Serigne N., Drummond, Martin, Star, Phoebe, Fogarty, Gerald B., Hong, Angela M., Guitera, Pascale

Repurposing azacitidine and carboplatin to prime immune checkpoint blockade-resistant melanoma for anti-PD-L1 re-challenge

- van der Westhuizen, Andre, Lyle, Megan, Vilain, Ricardo E., Bowden, Nikola A., Graves, Moira C., Zhu, Xiaoqiang, Wong, Jason W. H., Cornall, Kerrie, Ren, Shu, Pugliese, Leanna, Levy, Richard, Majid, Adeeb

Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma

- Maddison, Kelsey, Graves, Moira C., Bowden, Nikola A., Fay, Michael, Vilain, Ricardo E., Faulkner, Sam, Tooney, Paul A.

Monitoring patient response to pembrolizumab with peripheral blood exhaustion marker profiles

- Graves, Moira, CelliMarchett, Giovana, van Zyl, Belinda, Tang, Denise, Vilain, Ricardo E., van der Westhuizen, Andre, Bowden, Nikola A.

Sclerosing paraganglioma of the carotid body in a child: A diagnostic and therapeutic challenge

- Blefari, Nicholas D. A., Eliezer, Dilharan D., Vilain, Ricardo E., Hesketh, Elizabeth E., Deshpande, Arvind, Deshpande, Aniruddh V.

Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer

- Scurry, James, van Zyl, Belinda, Gulliver, Damien, Otton, Geoffrey, Jaaback, Kenneth, Lombard, Janine, Vilain, Ricardo E., Bowden, Nicola A.

Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair

- Budden, Timothy, Davey, Ryan J., Vilain, Ricardo E., Ashton, Katie A., Braye, Stephen G., Beveridge, Natalie J., Bowden, Nikola A.

The regenerating naevus

- Vilain, Ricardo E., McCarthy, Stanley W., Scolyer, Richard A.

Regulators of global genome repair do not respond to DNA damaging therapy but correlate with survival in melanoma

- Bowden, Nikola A., Ashton, Katie A., Scott, Rodney J., Vilain, Ricardo E., Avery-Kiejda, Kelly A., Davey, Ryan J., Murray, Heather C., Budden, Timothy, Braye, Stephen G., Zhang, Xu Dong, Hersey, Peter